Receptor for advanced glycation end products inhibits proliferation in osteoblast through suppression of Wnt, PI3K and ERK signaling

被引:52
作者
Li, Guofeng [1 ]
Xu, Jingren [2 ]
Li, Zengchun [1 ]
机构
[1] Tongji Univ, Sch Med, East Hosp, Dept Emergency Surg, Shanghai 200120, Peoples R China
[2] Tongji Univ, Sch Med, East Hosp, Dept Tradit Chinese Orthopaed, Shanghai 200120, Peoples R China
关键词
RAGE; Cell proliferation; PI3K; Wnt; ERK; BONE MASS; MISSENSE MUTATIONS; LRP5; GENE; PATHWAY; PROTEIN-5; DECREASE; DENSITY; FAMILY; RAGE;
D O I
10.1016/j.bbrc.2012.06.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of receptor for advanced glycation end products (RAGE) plays a crucial role in bone metabolism. However, the role of RAGE in the control of osteoblast proliferation is not yet evaluated. In the present study, we demonstrate that RAGE overexpression inhibits osteoblast proliferation in vitro. The negative regulation of RAGE on cell proliferation results from suppression of Wnt, PI3K and ERK signaling, and is restored by RAGE neutralizing antibody. Prevention of Wnt signaling using Sfrp1 or DKK1 rescues RAGE-decreased PI3K and ERK signaling and cell proliferation, indicating that the altered cell growth in RAGE overexpressing cells is in part secondary to alterations in Wnt signaling. Consistently, RAGE overexpression inhibits the expression of Wnt targets cyclin D1 and c-myc, which is partially reversed by RAGE blockade. Overall, these results suggest that RAGE inhibits osteoblast proliferation via suppression of Wnt, PI3K and ERK signaling, which provides novel mechanisms by which RAGE regulates osteoblast growth. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:684 / 689
页数:6
相关论文
共 50 条
  • [31] NRSN2 promotes osteosarcoma cell proliferation and growth through PI3K/Akt/MTOR and Wnt/β-catenin signaling
    Keremu, Ajimu
    Maimaiti, Xiayimaierdan
    Aimaiti, Abudusaimi
    Yushan, Maimaiaili
    Alike, Yamuhanmode
    Yilihamu, Yilizati
    Yusufu, Aihemaitijiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (03): : 565 - 573
  • [32] CAMK1D Inhibits Glioma Through the PI3K/AKT/mTOR Signaling Pathway
    Jin, Qianxu
    Zhao, Jiahui
    Zhao, Zijun
    Zhang, Shiyang
    Sun, Zhimin
    Shi, Yunpeng
    Yan, Hongshan
    Wang, Yizheng
    Liu, Liping
    Zhao, Zongmao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Topiramate inhibits the proliferation of bladder cancer cells via PI3K/AKTR signaling pathway
    Chao, Liu
    Zhang, Shaoqi
    Zhang, Jianjun
    Cai, Longjun
    Wang, Xiangyu
    Meng, Fanlai
    Cai, Weiqi
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (04) : 685 - 691
  • [34] Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway
    Liu, Yingshan
    Zhang, Yan
    Jia, Kun
    Dong, Yuhao
    Ma, Weiyuan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (04) : 1401 - 1406
  • [35] PRDM4 inhibits cell proliferation and tumorigenesis by inactivating the PI3K/AKT signaling pathway through targeting of PTEN in cervical carcinoma
    Yang, Wen-Ting
    Chen, Mei
    Xu, Rui
    Zheng, Peng-Sheng
    ONCOGENE, 2021, 40 (18) : 3318 - 3330
  • [36] 10% HA/SPEEK/PEEK composite promotes proliferation and differentiation of osteoblast cells through the MAPK and PI3K/AKT signaling pathways
    Ren, Yinghua
    Ni, Zhuo
    Wang, Yang
    Zhang, Liqun
    Liu, Gengbo
    Liu, Xue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2127 - 2136
  • [37] Wnt5a silencing inhibits the osteosarcoma migration by suppressing PI3K/AKT signaling pathway
    Chen, Jun
    Wang, Ye
    Shi, Wei-Xin
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2014, 9 (04) : 533 - 538
  • [38] Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs
    Lee, Eun Jung
    Kim, Ji Young
    Oh, Sang Ho
    SCIENTIFIC REPORTS, 2016, 6
  • [39] Fentanyl inhibits the progression of gastric cancer through the suppression of MMP-9 via the PI3K/Akt signaling pathway
    Li, Chunlai
    Qin, Yi
    Zhong, Yu
    Qin, Yinying
    Wei, Yi
    Li, Li
    Xie, Yubo
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (04)
  • [40] Prucalopride inhibits lung cancer cell proliferation, invasion, and migration through blocking of the PI3K/AKT/mTor signaling pathway
    Chen, M.
    Zhu, L-L
    Su, J-L
    Li, G-L
    Wang, J.
    Zhang, Y-N
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2020, 39 (02) : 173 - 181